Structure, function and regulation of carboxylesterases

Chemico-Biological Interactions

Volumn 162, Issue 3, 2006, Pages 195-211

  Satoh, Tetsuo ^a,b   Hosokawa, Masakiyo ^a,c  

^a CHIBA UNIVERSITY   (Japan)

^b BUILDING RESEARCH INSTITUTE   (Japan)

^c CHIBA INSTITUTE OF SCIENCE   (Japan)

Author keywords

Carboxylesterases; Drug metabolism; Enzyme induction; Function; Gene expression; Molecular structure; Novel nomenclature and classification; Regulation

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; AMINOPHENAZONE; ANTINEOPLASTIC AGENT; BENAZEPRIL; CAPECITABINE; CARBOXYLESTERASE; CILAZAPRIL; CLOFIBRATE; COMPACTIN; DELAPRIL; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTER DERIVATIVE; IMIDAPRIL; IRINOTECAN; ISOENZYME; METHYLPHENIDATE; METHYLPREDNISOLONE SODIUM SUCCINATE; NARCOTIC AGENT; ORGANOPHOSPHATE INSECTICIDE; OXYBUTYNIN; PEROXISOME PROLIFERATOR; PHENOBARBITAL; PROCAINE; PRODRUG; QUINAPRIL; STEROID; TEMOCAPRIL; UNINDEXED DRUG; XENOBIOTIC AGENT;

AMINO ACID SEQUENCE; BLOOD BRAIN BARRIER; CANCER CELL; CATALYSIS; CLASSIFICATION; CRYSTAL STRUCTURE; DEACYLATION; DRUG ACTIVATION; DRUG DETOXIFICATION; DRUG DISTRIBUTION; DRUG HYDROLYSIS; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENCY; DRUG SELECTIVITY; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME LOCALIZATION; ENZYME MECHANISM; ENZYME REGULATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE STRUCTURE; GENETIC ANALYSIS; HUMAN; HYDROGEN BOND; HYDROLYSIS; LIVER CELL; LUNG CANCER; MOLECULAR CLONING; MOLECULAR INTERACTION; MUTATIONAL ANALYSIS; NOMENCLATURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; STRUCTURE ACTIVITY RELATION; TISSUE DISTRIBUTION; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; ANIMALS; CARBOXYLIC ESTER HYDROLASES; ENZYME INDUCTION; HUMANS; INSECTICIDES; MOLECULAR SEQUENCE DATA; ORGANOPHOSPHORUS COMPOUNDS; STRUCTURE-ACTIVITY RELATIONSHIP; TERMINOLOGY;

MAMMALIA;

EID: 33748744628     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2006.07.001     Document Type: Review

References (89)

1. Cygler M., Schrag J.D., Sussman J.L., Harel M., Silman L., Gentry M.K., and Doctor B.P. Relationship between sequence conservation and three-dimensional structure in a large family of esterases, lipases, and related proteins. Protein Sci. 2 (1993) 366-382
2. Satoh T., Taylor P., Bosron W.F., Sanghani S.P., Hosokawa M., and La Du B.N. Current progress on esterases: from molecular structure to function. Drug Metab. Dispos. 30 (2002) 488-493
3. Hosokawa M., Maki T., and Satoh T. Multiplicity and regulation of hepatic microsomal carboxylesterases in rats. Mol. Pharmacol. 31 (1987) 579-584
4. Hosokawa M., Maki T., and Satoh T. Characterization of molecular species of liver microsomal carboxylesterases of several animal species and humans. Arch. Biochem. Biophys. 277 (1990) 219-227
5. Hosokawa M., Endo Y., Fujisawa M., Hara S., Iwata N., Sato Y., and Satoh T. Interindividual variation in carboxylesterase levels in human liver microsomes. Drug Metab. Dispos. 23 (1995) 1022-1027
6. Hosokawa M., Suzuki K., Takahashi D., Mori M., Satoh T., and Chiba K. Purification, molecular cloning, and functional expression of dog liver microsomal acyl-CoA hydrolase: a member of the carboxylesterase multigene family. Arch. Biochem. Biophys. 389 (2001) 245-253
7. Maki T., Hosokawa M., Satoh T., and Sato K. Changes in carboxylesterase isoenzymes of rat liver microsomes during hepatocarcinogenesis. Jpn. J. Cancer Res. 82 (1991) 800-806
8. Satoh T., Hosokawa M., Atsumi R., Suzuki W., Hakusui H., and Nagai E. Metabolic activation of CPT-11, 7-ethyl-10-[4-(1-piperidino)-1-piperidinol] carbonyloxycamptothecin, a novel antitumor agent, by carboxylesterase. Biol. Pharm. Bull. 17 (1994) 662-664
9. Yamada T., Hosokawa M., Satoh T., Moroo I., Takahashi M., Akatsu H., and Yamamoto T. Immunohistochemistry with an antibody to human liver carboxylesterase in human brain tissues. Brain Res. 658 (1993) 163-167
10. Satoh T., and Hosokawa M. Mol[e]cular aspects of carboxylesterase isoforms in comparison with other esterases. Toxicol. Lett. (Shannon) 82 (1995) 439-445
11. Satoh T., and Hosokawa M. The mammalian carboxylesterases: from molecules to functions. Annu. Rev. Pharmacol. Toxicol. 38 (1998) 257-288
12. Morgan E.W., Yan B., Greenway D., Peterson D.R., and Parkinson A. Purification and characterization of two rat liver carboxylesterase. Arch. Biochem. Biophys. 315 (1994) 495-512
13. Hosokawa M., Maki T., and Satoh T. Differences in the induction of carboxylesterase isozymes in rat liver microsomes by xenobiotics. Biochem. Pharmacol. 37 (1988) 2708-2711
14. Hosokawa M., and Satoh T. Differences in the induction of carboxylesterases isozymes in rat liver microsomes by perfluorinated fatty acids. Xenobiotica 23 (1993) 1125-1133
15. Hosokawa M., Hirata K., Nakata F., Suga T., and Satoh T. Species differences in the induction of hepatic microsomal carboxylesterases caused by dietary exposure to di(2-ethylhexyl)phthalate, a peroxisome proliferator. Drug Metab. Dispos. 22 (1994) 889-894
16. Furihata T., Hosokawa M., Koyano N., Nakamura T., Satoh T., and Chiba K. Identification of di-(2-ethylhexyl) phthalate-induced carboxylesterase 1 in C57BL/6 mouse liver microsomes: purification, cDNA cloning, and baculovirus-mediated expression: identification of the cytosolic carboxylesterase catalyzing the 5′-deoxy-5-fluorocytidine formation from capecitabine in human liver. Drug Metab. Dispos. 32 (2004) 1170-1177
17. Furihata T., Hosokawa M., Nakata F., Satoh T., and Chiba K. Purification, molecular cloning, and functional expression of inducible liver acylcarnitine hydrolase in C57BL/6 mouse, belonging to the carboxylesterase multigene family. Arch. Biochem. Biophys. 416 (2003) 101-109
18. Aldridge W.N. The esterases: perspectives and problems. Chem. Biol. Interact. 87 (1993) 5-13
19. Mentlein R., Suttorp M., and Heymann E. Specificity of purified monoacylglycerol lipase, palmitoyl-CoA hydrolase, palmitoyl-carnitine hydrolase, and nonspecific carboxylesterase from rat liver microsomes. Arch. Biochem. Biophys. 228 (1984) 230-246
20. Miyazaki M., Kamiie K., Soeta S., Taira H., and Yamashita T. Molecular cloning and characterization of a novel carboxylesterase-like protein that is physiologically present at high concentrations in the urine of domestic cats (Felis catus). Biochem. J. 370 (2003) 101-110
21. Watanabe K., Kayano Y., Matsunaga T., Yamamoto I., and Yoshimura H. Purification and characterization of a novel 46.5-kilodalton esterase from mouse hepatic microsomes. Biochem. Mol. Biol. Int. 31 (1993) 25-30
22. Kusano K., Seko T., Tanaka S., Shikata Y., Ando T., Ida S., Hosokawa M., Satoh T., Yuzuriha T., and Horie T. Purification and characterization of monkey liver amidohydrolases and its relationship to a metabolic polymorphism of E6123, a platelet activating factor receptor antagonist. Drug. Metab. Didpos. 24 (1996) 1186-1191
23. Takayama H., Watanabe A., Hosokawa M., Chiba K., Satoh T., and Aimi N. Synthesis of a new class of camptothencin derivatives, the long-chain fatty acid esters of 10-hydrocamptothencin, as a potent prodrug candidate, and their in vitro metabolic conversion by carboxylesterases. Bioorg. Med. Chem. Lett. 8 (1998) 415-418
24. Mori M., Hosokawa M., Ogasawara Y., Tsukada E., and Chiba K. cDNA cloning, characterization and stable expression of novel human brain carboxylesterase. FEBS Lett. 458 (1999) 17-22
25. Li B., Sedlacek M., Manoharan I., Boopathy R., Duysen E.G., Masson P., and Lockridge O. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma. Biochem. Pharmacol. 70 (2005) 1673-1684
26. Fox C.A., Sappiro L.M., Zhang H., Zhang W., McLeod H.L., Petroni G.R., Mullick T., Moskaluk C.A., Frierson H.F., Hampton G.M., and Powell S.M. Altered expression of TFF-1 and CES-2 in Barrett's Esophagus and associated adenocarcinomas. Neoplasia 7 (2005) 407-416
27. Sanghani S.P., Davis W.I., Dumanual N.G., Mahrenholz A., and Bosro W.F. Identification of microsomal rat liver carboxylesterases and their activity with retinyl palmitate. Eur. J. Biochem. 296 (2002) 4387-4398
28. Sanghani S.P., Quinney S.K., Fredenburg T.B., Davis W.I., Murry D.J., and Bosron W.F. Hydrolysis of irinotecan and its oxidative metabolites, 7-ethyl-10-[4-N-{5-aminopentanoicacid}-1-piperidino]carbonyloxycamptothecin and 7-ethyl-10-[4-[piperidino]-1-amino-carbonylpxycamptothencin, by human carboxylesterases CES1A1, CES2, and a newly expressed carboxylesterase isozyme, CES3. Drug Metab. Dispos. 32 (2004) 505-511
29. Pfutzer R.H., Tadic S.D., Li H.S., Thompson B.S., Zhang J.Y., Ford M.E., Eagon P.K., and Whitcomb D.C. Pancreatic cholesterol esterase, ES-10, and fatty acid ethyl ester synthase III gene expression are increased in the pancreas and liver but not in the brain or heart with long-term ethanol feeding in rats. Pancreas 25 (2002) 101-106
30. Pelham H.R. The retention signal for soluble proteins of the endoplasmic reticulum. Trends Biochem. Sci. 15 (1990) 483-486
31. Tang B.K., and Kalow W. Variable activation of lovastatin by hydrolytic enzymes in human plasma and liver, 4. Eur. J. Clin. Pharmacol. 47 (1995) 449-451
32. Korza G., and Ozols J. Complete covalent structure of 60-kDa esterase isolated from 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced rabbit liver. J. Biol. Chem. 263 (1988) 3486-3495
33. Ozols J. Isolation, properties, and the complete amino acid sequence of a second form of 60-kDa glycoprotein esterase. J. Biol. Chem. 264 (1989) 12533-12545
34. Robbi M., Beaufay H., and Octave J.N. Nucleotide sequence of cDNA coding for rat liver pI 6.1 esterase (ES-10), a carboxylesterase located in the lumen of the endoplasmic reticulum. Biochem. J. 269 (1990) 451-458
35. Robbi M., and Beaufay H. Cloning and sequencing of rat liver carboxylesterase ES-3 (egasyn). Biochem. Biophys. Res. Commun. 203 (1994) 1404-1411
36. Medda S., Takeuchi K., Devore-Carter D., von Deimling O., Heymann E., and Swank R.T. An accessory protein identical to mouse egasyn is complexed with rat microsomal beta-glucuronidase and is identical to rat esterase-3. J. Biol. Chem. 262 (1987) 7248-7253
37. Ovnic M., Swank R.T., Fletcher G., Zhen L., Novak E.K., Baumann H., Heintz N., and Ganschow R.E. Characterization and functional expression of a cDNA encoding egasyn (esterase-22): the endoplasmic reticulum-targeting protein of beta-glucuronidase. Genomics 11 (1991) 956-967
38. Shibata F., Takagi Y., Kitajima M., Kuroda T., and Omura T. Molecular cloning and characterization of a human carboxylesterase gene. Genomics 17 (1993) 76-82
39. von Heijne G. Patterns of amino acids near signal-sequence cleavage sites. Eur. J. Biochem. 133 (1983) 17-21
40. Frey P.A., Whitt S.A., and Tobin J.B. A low-barrier hydrogen bond in the catalytic triad of serine proteases. Science 264 (1994) 1927-1930
41. Bencharit S., Morton G.L., Hyatt J.L., Kuhn P., Danks M.K., Potter P.M., and Redinbo M.R. Crystal structure of human carboxylesterase 1 complexed with the Alzheimer's drug tacrine: from binding promiscuity to selective inhibition. Chem. Biol. 10 (2003) 341-349
42. Bencharit S., Morton C.L., Howard-Williams E.L., Danks M.K., Potter P.M., and Redinbo M.R. Structural insights into CPT-11 activation by mammalian carboxylesterases. Nat. Struct. Biol. 9 (2002) 337-342
43. Bencharit S., Morton C.L., Xue Y., Potter P.M., and Redinbo M.R. Structural basis of heroin and cocaine metabolism by a promiscuous human drug-processing enzyme. Nat. Struct. Biol. 10 (2003) 349-356
44. Wong H., and Schotz M.C. The lipase gene family. J. Lipid. Res. 43 (2002) 993-999
45. Wallace T.J., Ghosh S., and McLean Grogan W. M[ol?]ecular cloning and expression of rat lung carboxylesterase and its potential role in the detoxification of organophosphorus compounds. Am. J. Respir. Cell Mol. Biol. 20 (1999) 1201-1208
46. Langmann T., Becker A., Aslanidis C., Notka F., Ullrich H., Schwer H., and Schmitz G. Structural organization and characterization of the promoter region of a human carboxylesterase gene. Biochim. Biophys. Acta 135 (1997) 65-74
47. Zschunke F., Salmassi A., Kreipe H., Buck F., Parwaresch M.R., and Radzun M.J. cDNA cloning and characterization of human monocyte/macrophage serine esterase-1. Blood 78 (1991) 506-512
48. Kroetz D.L., McBride O.W., and Gonzalez F.J. Glycosylation-dependent activity of baculovirus-expressed human liver carboxylesterases: cDNA cloning and characterization of two highly similar enzyme forms. Biochemistry 32 (1993) 11606-11617
49. Furihata T., Hosokawa M., Masuda M., Satoh T., and Chiba K. Hepatocyte nuclear factor-4alpha plays pivotal roles in the regulation of mouse carboxylesterase 2 gene transcription in mouse liver. Arch. Biochem. Biophys. 447 (2006) 107-117
50. Wu M.H., Chen P., Remo B.F., Cook Jr. E.H., Das S., and Dolan M.E. Characterization of multiple promoters in the human carboxylesterase 2 gene. Pharmacogenetics 13 (2003) 425-435
51. Furihata T., Hosokawa M., Satoh T., and Chiba K. Synergistic role of specificity proteins and upstream stimulatory factor 1 in transactivation of the mouse carboxylesterase 2microsomal acylcarnitine hydrolase gene promoter. Biochem. J. 384 (2004) 101-110
52. Wu M.H., Chen P., Wu X., Liu W., Strom S., Das S., Cook Jr. E.H., Rosner G.L., and Dolan M.E. Determination and analysis of single nucleotide polymorphisms and haplotype structure of the human carboxylesterase 2 gene. Pharmacogenetics 14 (2004) 595-605
53. Kim S.R., Nakamura T., Saito Y., Sai K., Nakajima T., Saito H., Shirao K., Minami H., Ohtsu A., Yoshida T., Saijo N., Ozawa S., and Sawada J. Twelve novel single nucleotide polymorphisms in the CES2 gene encoding human carboxylesterase 2 (hCE-2). Drug Metab. Pharmacokenet. 18 (2003) 327-332
54. Ovnic M., Tepperman K., Medda S., Elliott R.W., Stephenson D.A., Grant S.G., and Ganschow R.E. Characterization of a murine cDNA encoding a member of the carboxylesterase multigene family. Genomics 9 (1991) 344-354
55. Takai S., Matsuda A., Usami Y., Adachi T., Sugiyama T., Katagiri Y., Tatematsu M., and Hirano K. Hydrolytic profile for ester- or amide-linkage by carboxylesterases pI 5.3 and 4.5 from human liver. Biol. Pharm. Bull. 20 (1997) 869-873
56. Tabata T., Katoh M., Tokudome S., Nakajima M., and Yokoi T. Identification of the cytosolic carboxylesterase catalyzing the 5′-deoxy-5-fluorocytidine formation from capecitabine in human liver. Drug. Metab. Dispos. 32 (2004) 1103-1110
57. Xie M., Yang D., Wu M., Xue B., and Yan B. Mouse liver and kidney carboxylesterase (M-LK) rapidly hydrolyzes antitumor prodrug irinotecan and the N-terminal three quarter sequence determines substrate selectivity. Drug Metab. Dispos. 31 (2003) 21-27
58. Ohtsuka K., Inoue S., Kameyama M., Kanetoshi A., Fujimoto T., Takaoka K., Araya Y., and Shida A. Intracellular conversion of irinotecan to its active form, SN-38, by native carboxylesterase in human non-small cell lung cancer. Lung Cancer 41 (2003) 187-198
59. Charasson V., Bellott R., Meynard D., Longy M., Gorry P., and Robert J. Pharmacogenetics of human carboxylesterase 2, an enzyme involved in the activation of irinotecan into SN-38. Clin. Pharmacol. Ther. 76 (2004) 528-535
60. Marsh S., Xiao M., Yu J., Ahluwalia R., Minton M., Freimuth R.R., Kwok P.Y., and McLeod H.L. Pharmacogenomics assessment of carboxylesterases 1 and 2. Genomics 84 (2004) 661-668
61. Mattes C., Bradley R., Slaughter E., and Browne S. Cocain and butyrylcholinesterase (BchE). Determination of enzymatic properties. Pharmacol. Lett. 58 (1996) 257-261
62. Lynch T.Y., Mattes C.E., Singh A., Bradley R.M., Bradley R.O., and Dretchen K.L. Cocaine detoxification by human plasma butyrylcholinesterase. Toxicol. Appl. Pharmacol. 145 (1997) 363-371
63. Pindel E.V., Kedishvili M.Y., Abraham T.L., Brzezinski M.R., Zhang J., Dean R.A., and Bosron W.F. Purification and cloning of a broad substrate specificity human liver carboxylesterase that catalyzes the hydrolysis of cocaine and heroin. J. Biol. Chem. 272 (1997) 14769-14775
64. Kamendulis L.M., Brzezinski M.R., Pindel E.V., Bosron W.F., and Dean R.A. Metabolism of cocaine and heroin is catalyzed by the same human liver carboxylesterases. J. Pharmacol. Exp. Ther. 279 (1996) 713-717
65. Zhang J., Burnell J.C., Dumaual N., and Bosron W.F. Binding and hydrolysis of meperidine by human liver carboxylesterase hCE-1. J. Pharmacol. Exp. Ther. 290 (1999) 314-318
66. Kamendulis L.M., Brzezinski M.R., Pindel E.V., Bosron W.F., and Dean R.A. Metabolism of cocaine and heroin is catalyzed by the same human liver carboxylesterases. J. Pharmacol. Exp. Ther. 279 (1996) 713-717
67. Inoue M., Morikawa M., Tsuboi M., and Sugiura M. Species difference and characterization of intestinal esterase on the hydrolizing activity of ester-type drugs. Jpn. J. Pharmacol. 29 (1979) 9-16
68. Prueksaritanont T., Gorham L.M., Hochman J.H., Tran L.O., and Vyas K.P. Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells. Drug Metab. Dispos. 24 (1996) 634-642
69. Zhu W., Song L., Zhang H., Matoney L., LeCluyse E., and Yan B. Dexamethasone differentially regulates expression of carboxylesterase genes in humans and rats. Drug Metab. Dispos. 28 (2000) 186-191
70. Geshi E., Kimura T., Yoshimura M., Suzuki H., Koba S., Sakai T., saito T., Koga A., Muramatsu M., and Katagiri T. A single nucleotide polymorphism in the carboxylesterase gene is associated with the responsiveness to imidapril medication and the promoter activity. Hypertens. Res. 28 (2005) 719-725
71. Fleming C.D., Bencharit S., Edwards C.C., Hyatt J.L., et al. Structural insights into drug processing by human carboxylesterase 1: tamoxifen, mevastatin, and inhibition by benzyl. J. Mol. Biol. 352 (2005) 165-177
72. Dolinsky V.W., Gilham D., Alam M., Vance D.E., and Lehner R. Triglycerol hydrolase:role in intracellular lipid metabolism. Cell Mol. Life Sci. 61 (2004) 1633-1651
73. Sun Z., Murry D.J., Sanghani S.P., Davis W.I., Kedishvili N.Y., Zou Q., Hurley T.D., and Bosron W.F. Methylphenidate is stereoselectively hydrolyzed by human carboxylesterase CES1A1. J. Pharmacol. Exp. Ther. 310 (2004) 469-476
74. Imai T., Yoshigae Y., Hosokawa M., Chiba K., and Otagiri M. Evidence for the involvement of a pulmonary first-pass effect via carboxylesterase in the disposition of a propranolol ester derivative after intravenous administration. J. Pharmacol. Exp. Ther. 307 (2003) 1234-1242
75. Sanghani S.P., Quinney S.K., Fredenburg T.B., Sun Z., Davis W.I., Murry D.J., Cummings O.W., Seitz D.E., and Bosron W.F. Carboxylesterases expressed in human colon tumor tissue and their role in CPT-11 hydrolysis. Clin. Cancer Res. 9 (2003) 4983-4991
76. Lentz F., Tran A., Rey E., Pons G., and Treluyer J.M. Pharmacogenomics of fluorouracil, irinotecan, and oxaliplatin in hepatic metastases of colorectal cancer:clinical implications. Am. J. Pharmacogenomics 5 (2005) 21-33
77. Howarth J.A., Price S.C., Dobrota M., Kentish P.A., and Hinton R.H. Effects on male rats of di-(2-ethylhexyl) phthalate and di-n-hexylphthalate administered alone or in combination. Toxicol. Lett. 121 (2001) 35-43
78. Aida K., Moore R., and Negishi M. Cloning and nucleotide sequence of a novel, male-predominant carboxylesterase in mouse liver. Biochim. Biophys. Acta 1174 (1993) 72-74
79. Dolinsky V.W., Sipione S., Lehner R., and Vance D.E. The cloning and expression of a murine triacylglycerol hydrolase cDNA and the structure of its corresponding gene. Biochim. Biophys. Acta 1532 (2001) 162-172
80. Furihata T., Hosokawa M., Fujii A., Derbel M., Satoh T., and Chiba K. Dexamethasone-induced methylprednisolone hemisuccinate hydrolase: Its identification as a member of the rat carboxylesterase 2 family and its unique existence in plasma. Biochem. Pharmacol. 69 (2005) 1287-1299
81. Hattori K., Igarashi M., Itoh M., Tomisawa H., Ozawa N., and Tateishi M. Purification and characterization of glucocorticoid-inducible steroid esterase in rat hepatic microsomes: specific induction by glucocorticoids of steroid esterase in rat hepatic microsomes and its release into serum. Biochem. Pharmacol. 43 (1992) 1929-1937
82. Yang D., Li Y., Yuan X., Matoney L., and Yan B. Regulation of rat carboxylesterase expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): a dose-dependent decrease in mRNA levels but a biphasic change in protein levels and activity. Toxicol. Sci. 64 (2001) 20-27
83. Kannius-Janson M., Lidberg U., Bjursell G., and Nilsson J. The tissue-specific regulation of the carboxyl ester lipase gene in exocrine pancreas differs significantly between mouse and human. Biochem. J. 351 Pt. 2 (2000) 367-376
84. Satoh T. Release of liver microsomal beta-glucuronidase from hepatocytes in vitro and in vivo by organophosphates and hepatotoxic agents. J. Toxicol. Sci. Suppl. 1 (1991) 133-142
85. Satoh T. Toxicological implications of esterases-From molecular structures to functions. Toxicol. Appl. Pharmacol. 297 (2005) S11-S18
86. Satoh T., Suzuki S., Kawai N., Nakamura T., and Hosokawa M. Toxicological significance in the cleavage of esterase-B-glucuronidase complex in liver microsomes by organophosphorus compounds. Chem. Biol. Interact. 119-120 (1999) 471-478
87. Satoh T., and Hosokawa M. Organophosphates and their impact on the global environment. Neurotoxicology 21 (2000) 223-228
88. Fujikawa Y., Satoh T., Suganuma A., Suzuki S., Niikura Y., Yui S., and Tamaura Y. Extremely sensitive biomarker of acute organophosphorus insecticide exposure. Hum. Exp. Toxicol. 24 (2005) 333-336
89. Ross M.K., Borazjani A., Edwards C.C., and Potter P.M. Hydrolyutic metabolism of pyrethroids by human and other mammalian carboxylesterases. Biochem. Pharmacol. 71 (2006) 657-669